drug pricing
Coverage of drug pricing in the Nexus archive.
- FIRST AID: Could Swiss pharma be next?
The article questions whether Swiss pharmaceutical companies might face similar challenges as those seen in illicit tobacco, food safety, and drug pricing. It highlights these three issues as potential areas of concern for the Swiss pharma industry.
- US launches trade investigation into Germany’s spending on new medicines
The US has launched a Section 301 trade investigation targeting Germany's spending on new medicines, escalating tensions in Washington's drug pricing dispute with Europe.
- Czechia urges caution on EU drug pricing amid US pressure [Advocacy Lab]
Czechia urges caution on EU drug pricing amid US pressure, supporting stronger EU cooperation but insisting governments retain control over pricing and reimbursement decisions.
- EU health chief says Brussels studying impact of Trump’s drug pricing threats
The EU health chief stated that Brussels is studying the impact of Trump’s drug pricing threats. Capitals are seeking clarity on which medicines could be affected.
- FIRST AID: French far right woos vapers
The French far right is targeting vapers as part of its outreach efforts. The article also covers topics such as drug pricing and budget discussions.
- AstraZeneca makes surprise U-turn with £300m pharma investment
AstraZeneca has reversed its decision to pause large-scale UK projects, pledging a £300m investment in the country after previously citing dissatisfaction with the NHS and drug pricing. The announcement, made by Keir Starmer, marks a surprise shift in the company's stance on the UK business environment.
- Trump says no nuclear weapon will be used on Iran
President Donald Trump stated that nuclear weapons would not be used against Iran, asserting that conventional methods have already been effective. He dismissed the question as 'stupid' and emphasized that there is no need for such action.